Influence of novel oral anticoagulants on anticoagulation care management

被引:2
|
作者
Janzic, Andrej [1 ]
Kos, Mitja [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
novel oral anticoagulants; health care management; anticoagulation care; NONVALVULAR ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; COST-EFFECTIVENESS; STROKE PREVENTION; GUIDELINES; PHYSICIANS; OPTIMIZE; QUALITY; CLINICS; MODELS;
D O I
10.1515/acph-2017-0030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Anticoagulation treatment was recently improved by the introduction of novel oral anticoagulants (NOACs). Using a combination of qualitative and quantitative methods, this study explores the effects of the introduction of NOACs on anticoagulation care in Slovenia. Face-to-face interviews with key stakeholders revealed evolvement and challenges of anticoagulation care from different perspectives. Obtained information was further explored through the analysis of nationwide data of drug prescriptions and realization of health care services. Simplified management of anticoagulation treatment with NOACs and their high penetration expanded the capacity of anticoagulation clinics, and consequentially the treated population increased by more than 50 % in the last 5 years. The main challenge concerned the expenditures for medicines, which increased approximately 10 times in just a few years. At the same time, the anticoagulation clinics and their core organisation were not affected, which is not expected to change, since they are vital in delivering high-quality care.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 50 条
  • [21] Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin
    Kim, Bum Joon
    Kang, Hyun Goo
    Lee, Deok Hee
    Kang, Dong-Wha
    Kim, Jong S.
    Kwon, Sun U.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (06) : E68 - E68
  • [22] Perioperative anticoagulation for patients receiving oral anticoagulants
    Meyer, J
    ANAESTHESIST, 1999, 48 (10): : 744 - 745
  • [23] Anticoagulation for Atrial Fibrillation: New Oral Anticoagulants?
    Omran, H.
    von der Recke, G.
    AKTUELLE KARDIOLOGIE, 2012, 1 (03) : 192 - 198
  • [24] Anticoagulation: a GP primer on the new oral anticoagulants
    Brieger, David
    Curnow, Jenny
    AUSTRALIAN FAMILY PHYSICIAN, 2014, 43 (05) : 254 - 259
  • [25] Acute management of bleeding in patients on novel oral anticoagulants
    Siegal, Deborah M.
    Crowther, Mark A.
    EUROPEAN HEART JOURNAL, 2013, 34 (07) : 489 - +
  • [26] Periprocedural management of patients receiving novel oral anticoagulants
    Pou, Paloma Arias
    Gonzalez, Aquerreta
    Prieto Martinez, Luis Jose
    Latorre, Amaya Delgado
    Alonso, Maria Serrano
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (06) : 292 - 297
  • [27] Management of novel oral anticoagulants in emergency and trauma surgery
    Pinho-Gomes, Ana-Catarina
    Hague, Adam
    Ghosh, Jonathan
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2016, 14 (04): : 234 - 239
  • [28] Role of Pharmacogenomics in the Management of Traditional and Novel Oral Anticoagulants
    Cavallari, Larisa H.
    Shin, Jaekyu
    Perera, Minoli A.
    PHARMACOTHERAPY, 2011, 31 (12): : 1192 - 1207
  • [29] Management of novel oral anticoagulants (NOAs) in minor surgery
    Curto, Adrian
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2016, 69 (08): : E161 - E161
  • [30] Novel oral anticoagulants in the management of coronary artery disease
    McMahon, Sean R.
    Brummel-Ziedins, Kathleen
    Schneider, David J.
    CORONARY ARTERY DISEASE, 2016, 27 (05) : 412 - 419